Evidence map›Paper›PMID 34250356›Full record

ArticleACS omega2021

New Approach to Drug Discovery of a Safe Mitochondrial Uncoupler: OPC-163493.

Takashi Okamoto, Takahiro Shimada, Chiharu Matsumura, Hitomi Minoshima, Takashi Ban, Motohiro Itotani, Toshio Shinohara, Shigekazu Fujita, Satoshi Matsuda, Seiji Sato and 1 more

Abstract read
In one paragraph

Article in ACS omega, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Takashi OkamotoDepartment of Lead Discovery Research, New Drug Research Division, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.
Takahiro ShimadaDepartment of Drug Metabolism and Pharmacokinetics, Nonclinical Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.
Chiharu MatsumuraMedicinal Chemistry Research Laboratories, New Drug Research Division, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.
Hitomi MinoshimaPharmaceutical Planning Group, Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan.
Takashi BanDepartment of Renal and Cardiovascular Research, New Drug Research Division, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.
Motohiro ItotaniQuality Assurance Section (Tokushima Wajiki Factory), Quality Assurance Department, Headquarters for Product Safety and Quality Assurance, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.
Toshio ShinoharaMedicinal Chemistry Research Laboratories, New Drug Research Division, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.
Shigekazu FujitaHuman Resources Department, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.
Satoshi MatsudaAdministration Department, Diagnostic Division, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.
Seiji SatoMedicinal Chemistry Research Laboratories, New Drug Research Division, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.ORCID https://orcid.org/0000-0003-2515-8261
Naohide KanemotoDepartment of Lead Discovery Research, New Drug Research Division, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We serendipitously found a mitochondrial uncoupler (mUncoupler), compound

Identifiers

PMID34250356
PMCPMC8264940

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.